市場調查報告書

稀少神經疾病治療的全球市場:至2027年的分析與預測(各適應症,各藥物類型,各流通管道,各投藥法,各地區)

Rare Neurological Disease Treatment Market to 2027 - Global Analysis and Forecasts by Indication, Drug Type, Distribution Channel, Mode of Administration and Geography

出版商 The Insight Partners 商品編碼 932084
出版日期 內容資訊 英文 183 Pages
訂單完成後即時交付
價格
稀少神經疾病治療的全球市場:至2027年的分析與預測(各適應症,各藥物類型,各流通管道,各投藥法,各地區) Rare Neurological Disease Treatment Market to 2027 - Global Analysis and Forecasts by Indication, Drug Type, Distribution Channel, Mode of Administration and Geography
出版日期: 2020年03月31日內容資訊: 英文 183 Pages
簡介

全球稀少神經疾病治療市場預測將從2019年的73億12萬美元以8.5%的年複合成長率擴大,到2027年達到138億96萬美元的規模。稀少神經疾病的罹患率上升和有利的開發平台藥物,稀少神經疾病治療的穩固研究活動支撐著市場成長。可是,治療費高顯示對市場成長的負面影響。作為稀少神經疾病的罹患率上升和對高齡化的對策,製藥公司積極參與藥物開發計劃。

本報告提供全球稀少神經疾病治療市場相關調查,市場概要和各市場區隔趨勢,各地區趨勢,及參與企業的簡介相關資訊彙整。

第1章 簡介

第2章 概要

第3章 調查方法

第4章 市場情況

  • 概要
  • PEST分析
  • 專家的見解

第5章 市場趨勢

  • 推動市場的要素
    • 稀少神經疾病罹患率上升
    • 有利的開發平台藥物與稀少神經疾病治療的穩固的研究活動
  • 阻礙市場的要素
    • 治療費高
  • 市場機會
    • 醫療基礎設施的充實和稀少神經疾病的認識度提高
  • 未來趨勢
    • 稀少神經疾病治療的人工智能
  • 影響分析

第6章 全球市場分析

  • 市場收益預測
  • 各地區市場
  • 參與企業的市場定位

第7章 各適應症市場分析

  • 概要
  • 各適應症市場佔有率
  • 猝睡症
  • 肌肉萎縮性側索硬化症
  • 阿茲海默症
  • 多發性硬化症
  • 脊髓性肌萎縮症
  • 裘馨氏肌肉萎縮症
  • 其他適應

第8章 各藥物類型市場分析

  • 概要
  • 各藥物類型市場佔有率
  • 有機成分
  • 生技藥品

第9章 各流通管道市場分析

  • 概要
  • 各流通管道市場佔有率
  • 線上藥局
  • 院內藥局
  • 零售藥局

第10章 各投藥法市場分析

  • 概要
  • 各投藥法市場佔有率
  • 口服
  • 注射

第11章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 中南美

第12章 COVID-19大流行帶給全球稀少神經疾病治療市場的影響

第13章 產業趨勢

  • 概要
  • 成長策略
  • 有機性發展
  • 無機性發展

第14章 企業簡介

第15章 附錄

目錄
Product Code: TIPRE00008485

The global rare neurological disease treatment market is expected to reach US$13,830.96 million by 2027 from US$ 7,300.12 million in 2019. The market is estimated to grow at a CAGR of 8.5% from 2020 to 2027.

Driving factors of the rare neurological disease treatment market are growing prevalence of rare neurological diseases and favorable pipeline drugs and robust research activities for the treatment of rare neurological diseases. However, high treatment cost incurred is likely to show negative impact on market growth during the forecast period.

Rapid developments in healthcare and drug discovery are leading to the introduction of new therapeutic solutions for the treatment of rare neurological diseases. Authorities such as World Health Organization, National Institute of Neurological Disorders and Stroke, and National Institutes of Health are taking constructive steps to encourage research activities to find a remedy for rare neurological diseases. For instance, in August 2019, National Institute of Neurological Disorders and Stroke and National Center for Advancing Translational Sciences invited researchers to conduct study on rare neurological and neuromuscular diseases.

In order to cope up with rising prevalence of rare neurological diseases and geriatric population, pharmaceutical companies are actively participating in the development of drugs.

For instance, in December 2019, Healx in partnership with Boehringer Ingelheim announced a plan to discover new treatment approaches in the coming years. Additionally, they are planning to discover new therapeutic options for the treatment of fragile X syndrome and Pitt-Hopkins syndrome. Additionally, in January 2020, Ovid Therapeutics, a well-known player in rare neurological diseases treatment market, announced the enrollment of patients for pivotal Phase 3 NEPTUNE trial associated with Angelman syndrome. The results of this research study are expected in mid-2020. Such increasing awareness and developments for rare neurological diseases are likely to boost the growth of the market during the forecast period.

The global rare neurological disease treatment market is segmented into indication, drug type, distribution channel, and mode of administration. The rare neurological disease treatment market, by indication, is further segmented into narcolepsy, amyotrophic lateral sclerosis, Alzheimer's disease, multiple sclerosis, spinal muscular atrophy (SMA), Duchene muscular dystrophy, and other indication. Based on drug type, the rare neurological disease treatment market is further segmented into organic compounds and biologics. Based on distribution channel, the market is further segmented into online pharmacies, hospital pharmacies, and retail pharmacies. The mode of administration segment is classified into oral, injectables.

Some of the essential primary and secondary sources included in the report are Food and Drug Administration, World Health Organization (WHO), Center for Drug Evaluation and Research, Canada Foundation of Innovation, European Federation of Pharmaceuticals Industries Associations, and International Trade Administration.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the rare neurological disease treatment market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global rare neurological disease treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Rare Neurological Disease Treatment Market- By Indication
    • 1.3.2 Global Rare Neurological Disease Treatment Market- By Drug Type
    • 1.3.3 Global Rare Neurological Disease Treatment Market- By Distribution Channel
    • 1.3.4 Global Rare Neurological Disease Treatment Market - By Mode of Administration
    • 1.3.5 Global Rare Neurological Disease Treatment Market- By Geography

2. Rare Neurological Disease Treatment Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Rare Neurological Disease Treatment- Market Landscape

  • 4.1 Overview
  • 4.2 Pest Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe- PEST Analysis
    • 4.2.3 Asia Pacific- PEST Analysis
    • 4.2.4 Middle East & Africa- PEST Analysis
    • 4.2.5 South and Central America - PEST Analysis

5. Rare Neurological Disease Treatment- Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Prevalence of Rare Neurological Diseases
    • 5.1.2 Favourable Pipeline Drugs and Robust Research Activities for the Treatment of Rare Neurological Diseases
  • 5.2 Key Market Restraints
    • 5.2.1 High Treatment Cost for Rare Neurological Diseases
  • 5.3 Key Market Opportunities
    • 5.3.1 Increasing Awareness of Rare Neurological Diseases Coupled with Developing Healthcare Infrastructure
  • 5.4 Future Trends
    • 5.4.1 Artificial Intelligence for the Treatment of Rare Neurological Diseases
  • 5.5 Impact Analysis

6. Rare Neurological Disease Treatment Market- Global Analysis

  • 6.1 Global Rare Neurological Disease Treatment Market Revenue Forecast And Analysis
  • 6.2 Global Rare Neurological Disease Treatment Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Rare Neurological Disease Treatment Market Analysis - By Indication

  • 7.1 Overview
  • 7.2 Rare Neurological Disease Treatment Market Share, by Indication, 2019 and 2027 (%)
  • 7.3 Narcolepsy
    • 7.3.1 Overview
    • 7.3.2 Narcolepsy: Rare Neurological Disease Treatment Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Amyotrophic Lateral Sclerosis
    • 7.4.1 Overview
    • 7.4.2 Amyotrophic Lateral Sclerosis: Rare Neurological Disease Treatment Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Alzheimer's Disease
    • 7.5.1 Overview
    • 7.5.2 Alzheimer's Disease: Rare Neurological Disease Treatment Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Multiple Sclerosis
    • 7.6.1 Overview
    • 7.6.2 Multiple Sclerosis: Rare Neurological Disease Treatment Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Spinal Muscular Atrophy (SMA)
    • 7.7.1 Overview
    • 7.7.2 Spinal Muscular Atrophy (SMA): Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.8 Duchenne Muscular Dystrophy
    • 7.8.1 Overview
    • 7.8.2 Duchenne Muscular Dystrophy: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.9 Other Indications
    • 7.9.1 Overview
    • 7.9.2 Other Indications: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)

8. Rare Neurological Disease Treatment Market Analysis - By Drug Type

  • 8.1 Overview
  • 8.2 Rare Neurological Disease Treatment Market Share, by Drug Type, 2019 and 2027, (%)
  • 8.3 Organic Compounds
    • 8.3.1 Overview
    • 8.3.2 Organic Compounds: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Biologics
    • 8.4.1 Overview
    • 8.4.2 Biologics: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)

9. Rare Neurological Disease Treatment Market Analysis - By Distribution Channel

  • 9.1 Overview
  • 9.2 Rare Neurological Disease Treatment Market Share, by Distribution Channel, 2019 and 2027, (%)
  • 9.3 Online Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Online Pharmacies: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.4 Hospital Pharmacies
    • 9.4.1 Overview
    • 9.4.2 Hospital Pharmacies: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 9.5 Retail Pharmacies
    • 9.5.1 Overview
    • 9.5.2 Retail Pharmacies: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)

10. Rare Neurological Disease Treatment Market Analysis - By Mode of Administration

  • 10.1 Overview
  • 10.2 Rare Neurological Disease Treatment Market Share, by Mode of Administration, 2019 and 2027 (%)
  • 10.3 Oral
    • 10.3.1 Overview
    • 10.3.2 Oral: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • 10.4 Inject able
    • 10.4.1 Overview
    • 10.4.2 Inject able: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)

11. Rare Neurological Disease Treatment Market - Geographic Analysis

  • 11.1 North America: Rare Neurological Disease Treatment Market
    • 11.1.1 Overview
    • 11.1.2 North America: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
    • 11.1.3 North America: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
    • 11.1.4 North America: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
    • 11.1.5 North America: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
    • 11.1.6 North America: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.1.7 North America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
    • 11.1.8 US: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.1 US: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.8.2 US: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.1.8.3 US: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.1.8.4 US: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.1.8.5 US: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.1.9 Canada: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.1 Canada: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.9.2 Canada: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.1.9.3 Canada: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.1.9.4 Canada: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.1.9.5 Canada: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.1.10 Mexico: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.1 Mexico: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.1.10.2 Mexico: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.1.10.3 Mexico: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
    • 11.1.11 Mexico: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.1.11.1 Mexico: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
  • 11.2 Europe: Rare Neurological Disease Treatment Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
    • 11.2.3 Europe: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
    • 11.2.4 Europe: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
    • 11.2.5 Europe: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
    • 11.2.6 Europe: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.2.7 Europe: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
    • 11.2.8 Germany: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.1 Germany: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.8.2 Germany: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.2.8.3 Germany: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.2.8.4 Germany: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.2.8.5 Germany: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.2.9 United Kingdom: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.1 United Kingdom: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.9.2United Kingdom: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.2.9.3 United Kingdom: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.2.9.4 United Kingdom: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.2.9.5 United Kingdom: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.2.10 France: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.1 France: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.10.2 France: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.2.10.3 France: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.2.10.4 France: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.2.10.5 France: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.2.11 Spain: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.1 Spain: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.11.2 Spain: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.2.11.3 Spain: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.2.11.4 Spain: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.2.11.5 Spain: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.2.12 Italy: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.1 Italy: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.2.12.2 Italy: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.2.12.3 Italy: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.2.12.4 Italy: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.2.12.5 Italy: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
  • 11.3 Asia Pacific: Rare Neurological Disease Treatment Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
    • 11.3.3 Asia Pacific: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
    • 11.3.4 Asia Pacific: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
    • 11.3.5 Asia Pacific: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
    • 11.3.6 Asia Pacific: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.3.7 Asia Pacific: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
    • 11.3.8 China: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.1 China: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.8.2 China: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.3.8.3 China: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.3.8.4 China: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.3.8.5 China: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.3.9 Japan: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.1 Japan: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.9.2 Japan: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.3.9.3 Japan: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.3.9.4 Japan: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.3.9.5 Japan: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.3.10 India: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.1 India: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.10.2 India: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.3.10.3 India: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.3.10.4 India: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.3.10.5 India: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.3.11 South Korea: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.1 South Korea: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.11.2 South Korea: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.3.11.3 South Korea: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.3.11.4 South Korea: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.3.11.5 South Korea: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.3.12 Australia: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.3.13.1 Australia: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.3.13.2 Australia: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.3.13.3 Australia: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.3.13.4 Australia: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
  • 11.4 Middle East & Africa: Rare Neurological Disease Treatment Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
    • 11.4.3 Middle East & Africa: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
    • 11.4.4 Middle East & Africa: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
    • 11.4.5 Middle East & Africa: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
    • 11.4.6 Middle East & Africa: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.4.7 Middle East & Africa: Rare Neurological Disease Treatment Market Share by Country - 2019 & 2027, (%)
    • 11.4.8 Saudi Arabia: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.8.1 Saudi Arabia: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.8.2 Saudi Arabia: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.4.8.3 Saudi Arabia: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.4.8.4 Saudi Arabia: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.4.8.5 Saudi Arabia: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.4.9 UAE: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.9.1 UAE: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.9.2 UAE: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.4.9.3 UAE: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.4.9.4 UAE: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.4.9.5 UAE: Rare Neurological Disease Treatment Market, by Distribution Channel , 2018-2027 (USD Million)
    • 11.4.10 South Africa: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
      • 11.4.10.1 South Africa: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.4.10.2 South Africa: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.4.10.3 South Africa: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.4.10.4 South Africa: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.4.10.5 South Africa: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
  • 11.5 South and Central America: Rare Neurological Disease Treatment Market
    • 11.5.1 Overview
    • 11.5.2 South and Central America: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
    • 11.5.3 South and Central America: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
    • 11.5.4 South and Central America: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
    • 11.5.5 South and Central America: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
    • 11.5.6 South and Central America: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.5.7 South and Central America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
    • 11.5.8 Brazil: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.1 Brazil: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.8.2 Brazil: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.5.8.3 Brazil: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.5.8.4 Brazil: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.5.8.5 Brazil: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)
    • 11.5.9 Argentina: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.1 Argentina: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
      • 11.5.9.2 Argentina: Rare Neurological Disease Treatment Market, by Indication, 2018-2027 (USD Million)
      • 11.5.9.3 Argentina: Rare Neurological Disease Treatment Market, by Drug Type, 2018-2027 (USD Million)
      • 11.5.9.4 Argentina: Rare Neurological Disease Treatment Market, by Mode of Administration, 2018-2027 (USD Million)
      • 11.5.9.5 Argentina: Rare Neurological Disease Treatment Market, by Distribution Channel, 2018-2027 (USD Million)

12. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact assessment of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

13. Rare Neurological Disease Treatment Market -Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies In The Rare Neurological Disease Treatment Market, 2017-2020
  • 13.3 Inorganic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Organic Growth Strategies
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 Allergan Plc.
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Bayer AG
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 GlaxoSmithKline plc.
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Johnson & Johnson Services, Inc.
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Merck & Co., Inc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Novartis AG
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Pfizer Inc.
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Sanofi
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Teva Pharmaceutical Industries Ltd
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Takeda Pharmaceutical Company Limited
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

LIST OF TABLES

  • Table 1. North America Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 3. North America Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 4. North America Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 5. US Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 6. US Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 7. US Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 8. US Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Canada Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Canada Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Canada Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Canada Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 13. Mexico Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 14. Mexico Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 15. Mexico Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 16. Mexico Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Europe Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Europe Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Europe Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Europe Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Germany Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Germany Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 23. Germany Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 24. Germany Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 25. United Kingdom Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 26. United Kingdom Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 27. United Kingdom Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 28. United Kingdom Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 29. France Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 30. France Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 31. France Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 32. France Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Spain Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Spain Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Spain Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Spain Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 37. Italy Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 38. Italy Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 39. Italy Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 40. Italy Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 41. Asia Pacific Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 42. Asia Pacific Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Asia Pacific Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 44. Asia Pacific Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 45. China Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 46. China Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 47. China Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 48. China Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 49. Japan Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 50. Japan Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 51. Japan Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 52. Japan Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 53. India Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 54. India Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 55. India Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 56. India Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 57. South Korea Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 58. South Korea Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 59. South Korea Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 60. South Korea Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 61. Australia Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 62. Australia Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 63. Australia Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 64. Australia Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 65. Middle East & Africa Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 66. Middle East & Africa Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 67. Middle East & Africa Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 68. Middle East & Africa Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 69. Saudi Arabia Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 70. Saudi Arabia Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 71. Saudi Arabia Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 72. Saudi Arabia Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 73. UAE Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 74. UAE Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 75. UAE Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 76. UAE Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 77. South Africa Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 78. South Africa Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 79. South Africa Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 80. South Africa Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 81. South and Central America Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 82. South and Central America Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 83. South and Central America Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 84. South and Central America Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 85. Brazil Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 86. Brazil Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 87. Brazil Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 88. Brazil Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 89. Argentina Rare Neurological Disease Treatment Market, by Indication - Revenue and Forecast to 2027 (USD Million)
  • Table 90. Argentina Rare Neurological Disease Treatment Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
  • Table 91. Argentina Rare Neurological Disease Treatment Market, by Mode of Administration - Revenue and Forecast to 2027 (USD Million)
  • Table 92. Argentina Rare Neurological Disease Treatment Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
  • Table 93. Recent Inorganic Growth Strategies In The Rare Neurological Disease Treatment Market
  • Table 94. Recent Organic Growth Strategies In The Rare Neurological Disease Treatment Market
  • Table 95. Glossary of Terms, Rare Neurological Disease Treatment Market

LIST OF FIGURES

  • Figure 1. Rare Neurological Disease Treatment Market Segmentation
  • Figure 2. Rare Neurological Disease Treatment, By Region
  • Figure 3. Global Rare Neurological Disease Treatment Market Overview
  • Figure 4. Alzheimer's Disease Segment Held Largest Share Of Indication Segment In Rare Neurological Disease Treatment Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Rare Neurological Disease Treatment Market, By Geography (US$ Million)
  • Figure 7. Global Rare Neurological Disease Treatment Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Rare Neurological Disease Treatment Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia pacific PEST Analysis
  • Figure 12. Middle East & Africa PEST Analysis
  • Figure 13. South and central America PEST Analysis
  • Figure 14. Rare Neurological Disease Treatment Market Impact Analysis Of Driver And Restraints
  • Figure 15. Global Rare Neurological Disease Treatment Market- Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Rare Neurological Disease Treatment Market- By Geography Forecast And Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Rare Neurological Disease Treatment Market
  • Figure 18. Rare Neurological Disease Treatment Market Share, by Indication, 2019 and 2027 (%)
  • Figure 19. Narcolepsy: Rare Neurological Disease Treatment Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Amyotrophic Lateral Sclerosis: Rare Neurological Disease Treatment Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Alzheimer's Disease: Rare Neurological Disease Treatment Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Multiple Sclerosis: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Spinal Muscular Atrophy (SMA): Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Duchenne Muscular Dystrophy: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Other Indications: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Rare Neurological Disease Treatment Market Share, by Drug Type, 2019 and 2027 (%)
  • Figure 27. Organic Compounds: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 28. Biologics: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. Rare Neurological Disease Treatment Market Share, by Distribution Channel, 2019 and 2027 (%)
  • Figure 30. Online Pharmacies: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Hospital Pharmacies: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Retail Pharmacies: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. Rare Neurological Disease Treatment Market Share, by Mode of Administration, 2019 and 2027 (%)
  • Figure 34. Oral: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 35. Injectable: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 36. North America: Rare Neurological Disease Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 37. North America Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)
  • Figure 38. North America: Rare Neurological Disease Treatment Market, by Country, 2019 & 2027 (%)
  • Figure 39. US: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Canada: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 41. Mexico: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 42. Europe: Rare Neurological Disease Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 43. Europe Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Europe: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
  • Figure 45. Germany: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. United Kingdom: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 47. France: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Spain: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. Italy: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 50. Asia Pacific: Rare Neurological Disease Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 51. Asia Pacific Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)
  • Figure 52. China: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. Japan: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. India: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. South Korea: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 56. Australia: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Middle East & Africa: Rare Neurological Disease Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 58. Middle East & Africa Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)
  • Figure 59. Middle East & Africa: Rare Neurological Disease Treatment Market Share by Country - 2019 & 2027, (%)
  • Figure 60. Saudi Arabia: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. UAE: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 62. South Africa: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 63. South and Central America: Rare Neurological Disease Treatment Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 64. South and Central America Rare Neurological Disease Treatment Market Revenue and Forecast to 2027 (USD Million)
  • Figure 65. South and Central America: Rare Neurological Disease Treatment Market, by Country, 2019& 2027 (%)
  • Figure 66. Brazil: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 67. Argentina: Rare Neurological Disease Treatment Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 68. Impact of COVID-19 Pandemic In North American Country Markets
  • Figure 69. Impact of COVID-19 Pandemic In European Country Markets
  • Figure 70. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
  • Figure 71. Impact Of COVID-19 Pandemic In North American Country Market
  • Figure 72. Growth Strategies in the Rare Neurological Disease Treatment Market, 2017-2020